Literature DB >> 22160195

Suggested pathway to assess radiation safety of 11C-labeled PET tracers for first-in-human studies.

Paolo Zanotti-Fregonara, Robert B Innis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22160195      PMCID： PMC3791506          DOI： 10.1007/s00259-011-2005-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  35 in total

1.  Radiation dosimetry of beta-amyloid tracers 11C-PiB and 18F-BAY94-9172.

Authors:  Graeme J O'Keefe; Timothy H Saunder; Steven Ng; Uwe Ackerman; Henri J Tochon-Danguy; J Gordon Chan; Sylvia Gong; Thomas Dyrks; Stefanie Lindemann; Gerhard Holl; Ludger Dinkelborg; Victor Villemagne; Christopher C Rowe
Journal:  J Nucl Med       Date:  2009-01-21       Impact factor: 10.057

2.  PET-derived biodistribution and dosimetry of the benzodiazepine receptor-binding radioligand (11)C-(R)-PK11195 in children and adults.

Authors:  Ajay Kumar; Otto Muzik; Diane Chugani; Pulak Chakraborty; Harry T Chugani
Journal:  J Nucl Med       Date:  2009-12-15       Impact factor: 10.057

3.  Radiation dosimetry and biodistribution of 11C-ABP688 measured in healthy volunteers.

Authors:  Valerie Treyer; Johannes Streffer; Simon M Ametamey; Andrea Bettio; Peter Bläuenstein; Mark Schmidt; Fabrizio Gasparini; Uta Fischer; Christoph Hock; Alfred Buck
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12-11       Impact factor: 9.236

4.  Human biodistribution and radiation dosimetry of 11C-(R)-PK11195, the prototypic PET ligand to image inflammation.

Authors:  Jussi Hirvonen; Anne Roivainen; Jere Virta; Semi Helin; Kjell Någren; Juha O Rinne
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10-28       Impact factor: 9.236

5.  Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PET.

Authors:  Charles M Laymon; N Scott Mason; W Gordon Frankle; Jonathan P Carney; Brian J Lopresti; Maralee Y Litschge; Chester A Mathis; James M Mountz; Rajesh Narendran
Journal:  J Nucl Med       Date:  2009-04-16       Impact factor: 10.057

6.  Human brain imaging and radiation dosimetry of 11C-N-desmethyl-loperamide, a PET radiotracer to measure the function of P-glycoprotein.

Authors:  Nicholas Seneca; Sami S Zoghbi; Jeih-San Liow; William Kreisl; Peter Herscovitch; Kimberly Jenko; Robert L Gladding; Andrew Taku; Victor W Pike; Robert B Innis
Journal:  J Nucl Med       Date:  2009-04-16       Impact factor: 10.057

7.  Whole-body biodistribution and radiation dosimetry in monkeys and humans of the phosphodiesterase 4 radioligand [(11)C](R)-rolipram: comparison of two-dimensional planar, bisected and quadrisected image analyses.

Authors:  David R Sprague; Masahiro Fujita; Yong Hoon Ryu; Jeih-San Liow; Victor W Pike; Robert B Innis
Journal:  Nucl Med Biol       Date:  2008-05       Impact factor: 2.408

8.  Biodistribution and radiation dosimetry of [(11)C]choline: a comparison between rat and human data.

Authors:  Tuula Tolvanen; Timo Yli-Kerttula; Tiina Ujula; Anu Autio; Pertti Lehikoinen; Heikki Minn; Anne Roivainen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01-13       Impact factor: 9.236

9.  Dosimetry of 11C-carfentanil, a micro-opioid receptor imaging agent.

Authors:  Andrew B Newberg; Riju Ray; Joshua Scheuermann; Nancy Wintering; Janet Saffer; Alexander Schmitz; Richard Freifelder; Joel Karp; Caryn Lerman; Chaitanya Divgi
Journal:  Nucl Med Commun       Date:  2009-04       Impact factor: 1.690

10.  PET-based biodistribution and radiation dosimetry of epidermal growth factor receptor-selective tracer 11C-PD153035 in humans.

Authors:  Ningbo Liu; Minghuan Li; Xiaoyu Li; Xue Meng; Guoren Yang; Shuqiang Zhao; Yi Yang; Li Ma; Zheng Fu; Jinming Yu
Journal:  J Nucl Med       Date:  2009-01-21       Impact factor: 10.057
View more
  22 in total

1.  [(11)C]TASP457, a novel PET ligand for histamine H3 receptors in human brain.

Authors:  Yasuyuki Kimura; Chie Seki; Yoko Ikoma; Masanori Ichise; Kazunori Kawamura; Keisuke Takahata; Sho Moriguchi; Tomohisa Nagashima; Tatsuya Ishii; Soichiro Kitamura; Fumitoshi Niwa; Hironobu Endo; Makiko Yamada; Makoto Higuchi; Ming-Rong Zhang; Tetsuya Suhara
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-02-23       Impact factor: 9.236

2.  (18)F-MCL-524, an (18)F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET Study.

Authors:  Sjoerd J Finnema; Vladimir Stepanov; Ryuji Nakao; Anna W Sromek; Tangzhi Zhang; John L Neumeyer; Susan R George; Philip Seeman; Michael G Stabin; Cathrine Jonsson; Lars Farde; Christer Halldin
Journal:  J Nucl Med       Date:  2014-05-01       Impact factor: 10.057

3.  Characterization of [11C]PXT012253 as a PET Radioligand for mGlu4 Allosteric Modulators in Nonhuman Primates.

Authors:  Akihiro Takano; Sangram Nag; Zhisheng Jia; Mahabuba Jahan; Anton Forsberg; Ryosuke Arakawa; Per Grybäck; Guillaume Duvey; Christer Halldin; Delphine Charvin
Journal:  Mol Imaging Biol       Date:  2019-06       Impact factor: 3.488

4.  11C-ER176, a Radioligand for 18-kDa Translocator Protein, Has Adequate Sensitivity to Robustly Image All Three Affinity Genotypes in Human Brain.

Authors:  Masamichi Ikawa; Talakad G Lohith; Stal Shrestha; Sanjay Telu; Sami S Zoghbi; Sabrina Castellano; Sabrina Taliani; Federico Da Settimo; Masahiro Fujita; Victor W Pike; Robert B Innis
Journal:  J Nucl Med       Date:  2016-11-17       Impact factor: 10.057

5.  Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.

Authors:  F Bretin; M A Bahri; C Bernard; G Warnock; J Aerts; N Mestdagh; T Buchanan; C Otoul; F Koestler; F Mievis; F Giacomelli; C Degueldre; R Hustinx; A Luxen; A Seret; A Plenevaux; E Salmon
Journal:  Mol Imaging Biol       Date:  2015-08       Impact factor: 3.488

6.  [11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson's disease and healthy volunteers.

Authors:  Donatienne Van Weehaeghe; Michel Koole; Mark E Schmidt; Stephanie Deman; Andreas H Jacobs; Erika Souche; Kim Serdons; Stefan Sunaert; Guy Bormans; Wim Vandenberghe; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-06-26       Impact factor: 9.236

Review 7.  Tactics for preclinical validation of receptor-binding radiotracers.

Authors:  Susan Z Lever; Kuo-Hsien Fan; John R Lever
Journal:  Nucl Med Biol       Date:  2016-09-03       Impact factor: 2.408

8.  Suggested pathway to assess radiation safety of ¹⁸F-labeled PET tracers for first-in-human studies.

Authors:  Paolo Zanotti-Fregonara; Adriaan A Lammertsma; Robert B Innis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-07-19       Impact factor: 9.236

9.  Comparison of two PET radioligands, [11C]FPEB and [11C]SP203, for quantification of metabotropic glutamate receptor 5 in human brain.

Authors:  Talakad G Lohith; Tetsuya Tsujikawa; Fabrice G Siméon; Mattia Veronese; Sami S Zoghbi; Chul Hyoung Lyoo; Yasuyuki Kimura; Cheryl L Morse; Victor W Pike; Masahiro Fujita; Robert B Innis
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 10.  Radiation Absorbed Dose to the Embryo and Fetus from Radiopharmaceuticals.

Authors:  Paolo Zanotti-Fregonara
Journal:  Semin Nucl Med       Date:  2022-01-21       Impact factor: 4.446
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.